Gordian Biotechnology – Trademark Portfolio
Entity Type: 03
Gordian Biotechnology holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include CREATING TIME. The owner is based in South San Francisco, CA.
486 Cabot Rd
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Gordian Biotechnology's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Gordian Biotechnology have?
Gordian Biotechnology has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 abandoned.
What trademark classes does Gordian Biotechnology file in?
Gordian Biotechnology files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Gordian Biotechnology's most well-known trademarks?
Gordian Biotechnology's registered trademark portfolio includes well-known marks such as CREATING TIME. These are among 1 currently registered trademark in the portfolio.
What is Gordian Biotechnology's trademark registration success rate?
Gordian Biotechnology has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.